Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 17,959 | 13,474 | 3,748 | 10,486 | 10,345 |
| Cost of Goods | 8,375 | 9,456 | 2,602 | 8,856 | 4,893 |
| Gross Profit | 9,584 | 4,018 | 1,146 | 1,630 | 5,452 |
| Operating Expenses | 5,968 | 6,901 | 6,604 | 8,101 | 8,232 |
| Operating Income | 3,991 | -2,427 | -4,856 | -5,615 | -1,887 |
| Other Income | -148 | 155 | 123 | -811 | 168 |
| Pre-tax Income | 3,843 | -2,272 | -4,733 | -6,426 | -1,719 |
| Income Tax | 607 | -69 | -138 | -382 | 133 |
| Net Income Continuous | 3,236 | -2,203 | -4,595 | -6,044 | -1,852 |
| Net Income | $3,236 | $-2,203 | $-4,595 | $-6,044 | $-1,852 |
| EPS Basic Total Ops | 0.04 | -0.03 | -0.06 | -0.09 | -0.03 |
| EPS Basic Continuous Ops | 0.04 | -0.03 | -0.06 | -0.08 | -0.03 |
| EPS Diluted Total Ops | 0.03 | -0.03 | -0.06 | -0.03 | -0.04 |
| EPS Diluted Continuous Ops | 0.04 | -0.03 | -0.06 | -0.06 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.03 | -0.03 | -0.06 | -0.07 | N/A |
| EBITDA(a) | $4,320 | $-2,108 | $-4,534 | $-5,243 | $-1,522 |